Recent strategies in the development of new human cytomegalovirus inhibitors.
- 6 April 2001
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 21 (3) , 227-244
- https://doi.org/10.1002/med.1008
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Design, Synthesis and Antiviral Activity of α-L-Arabinofuranosyl Derivatives of 2-Substituted-5,6-dichlorobenzimidazolesNucleosides and Nucleotides, 1998
- Synthesis and Antiviral Evaluation of Certain Novel Pyrazinoic Acid C-NucleosidesJournal of Medicinal Chemistry, 1998
- Evidence of a Conformational Change in the Human Cytomegalovirus Protease upon Binding of Peptidyl-Activated Carbonyl InhibitorsBiochemistry, 1997
- The Role of Hydrophobic Versus Hydrophilic Base Character in the Anti-HIV Activity of Purine-Containing PolyribonucleotidesNucleosides and Nucleotides, 1997
- Assembly of the Herpes Simplex Virus Capsid: Characterization of Intermediates Observed During Cell-free Capsid FormationJournal of Molecular Biology, 1996
- Novel, selective mechanism-based inhibitors of the herpes proteasesBioorganic & Medicinal Chemistry Letters, 1996
- Unique fold and active site in cytomegalovirus proteaseNature, 1996
- A new serine-protease fold revealed by the crystal structure of human cytomegalovirus proteaseNature, 1996
- Design, Synthesis, and Antiviral Activity of Certain 2,5,6-Trihalo-1-(.beta.-D-ribofuranosyl)benzimidazolesJournal of Medicinal Chemistry, 1995
- Unusual Single-Stranded Polyribonucleotides as Potent Anti-HIV AgentsJournal of Medicinal Chemistry, 1995